Clinical trials do not usually stall because the science is weak. They stall because the communication is.
Recruitment misses timelines. Participants do not fully understand what they are agreeing to. Sites interpret procedures differently. Patients struggle with study tasks between visits. Small misunderstandings can lead to protocol deviations, retraining, rework, and delays.
That is why video matters for CROs. Used strategically, video is not just a marketing asset. It is a trial-enablement tool that can help sponsors improve recruitment, informed consent, site readiness, patient adherence, and overall study consistency across the full trial lifecycle. Recruitment alone is one of the biggest pressure points in research: around 80% of trials fail to meet their initial enrollment target and timeline. (PubMed)
Recruitment Videos Help Sponsors Improve Enrollment Momentum
For many sponsors, the first challenge is not awareness. It is clarity.
Potential participants need to understand what the study is, who it is for, what will be required, and why it may be worth considering. Video helps CROs communicate those answers more clearly and quickly than dense text alone. That matters because video-based messaging has been shown to improve self-efficacy, behavioral intention, and even sign-up behavior among people new to clinical trials. In a 2024 JMIR study, doctor-led short-form clinical trial videos increased perceived source credibility, which in turn improved intent to participate and actual sign-up behavior. (JMIR)
For sponsors, that makes recruitment video more than a top-of-funnel asset. It becomes a tool for improving conversion quality, reducing mismatch, and creating better screening conversations earlier in the process. Recruitment delays are expensive, and even modest gains in enrollment efficiency can have meaningful downstream impact on timelines and study economics. (PubMed)
Study Overview and Consent Videos Improve Comprehension and Confidence
Informed consent is one of the most important communication moments in any trial. It is also one of the easiest places for confusion to undermine trust.
Video can help CROs support sponsors with consent and study-overview content that is clearer, more accessible, and easier to retain. In a 2024 JMIR Formative Research randomized experiment, 83.2% of participants in the video-consent group reported satisfaction with the overall consent process, versus 76.3% in the written-consent group. The video group also performed better on several individual comprehension items. (JMIR Formative Research)
That aligns with the broader evidence base. A Cochrane review of 16 studies involving 1,884 participants found that audiovisual consent interventions may improve knowledge and understanding of the parent trial, and participants receiving them were 3.3 times more likely to report satisfaction with the information provided. The same review found participants were 38% more likely to retain knowledge when tested two to four weeks later. (Cochrane)
For sponsors, better comprehension means more confident participants. For CROs, it means a practical way to reduce confusion-driven dropout risk and improve the participant experience from the very beginning.
Clinical Training Videos Help Standardize Site Execution
Multi-site trials depend on consistency, but achieving it is hard when critical procedures are communicated primarily through static documents, live calls, and one-time site initiation meetings.
This is where video becomes operationally powerful. Training videos can standardize how investigators and site teams learn protocol requirements, workflows, device handling, assessments, and reporting expectations. That matters because protocol deviations are not minor issues. A Tufts CSDD analysis published in Therapeutic Innovation & Regulatory Science found that Phase III protocols average 118.5 deviations, affecting about one-third of enrolled participants. The same paper notes that protocol deviations are a leading driver of clinical trial enforcement actions. (PMC)
The cost of downstream correction is also high. Tufts CSDD reported that the median direct cost to implement a substantial amendment was $141,000 for a Phase II protocol and $535,000 for a Phase III protocol. (PubMed)
For sponsors, clearer training is more than a convenience. It is a way to reduce variability, protect data quality, and limit avoidable rework. For CROs, it strengthens the case that they are improving trial execution, not just managing logistics.
Patient Training Videos Support Adherence Between Visits
Enrollment is only the start. Trials often create friction after consent, when participants are asked to follow instructions, use devices, complete ePRO tasks, prepare for visits, or self-administer treatment correctly over time.
Video helps solve that gap by showing, not just telling. Patient training videos can walk participants and caregivers through what to do, what to expect, and how to complete study tasks correctly. The broader evidence supports that approach: a 2023 systematic review found robust evidence that video-based educational tools improve patient knowledge, while a scoping review found that most empirical studies comparing video-based education with standard education reported a positive effect, especially for knowledge outcomes. (JMIR)
That matters more as protocols become more complex. Modern Phase III trials now generate vastly larger data loads and often depend on patients correctly using wearables, digital tools, and remote reporting systems. In that environment, clearer visual guidance can help reduce avoidable participant error and support stronger adherence over time. (PMC)
Multilingual Video Helps Sponsors Scale Globally Without Losing Consistency
Global trials get more complicated with every new region and language.
Video helps simplify that. Sponsors can use multilingual voiceover and subtitles, translated on-screen text and graphics, and the same core content across regions. That creates a more consistent experience for sites, participants, and stakeholders around the world.
It also makes updates easier. Instead of repeating live training across countries and teams, sponsors can update one core video asset and roll out the new version more efficiently.
For CROs, that means a smarter way to help sponsors scale globally while improving consistency, clarity, and control.
Video Helps CROs Deliver More Strategic Value to Sponsors
Sponsors are not only looking for a CRO that can run a study. They are looking for a partner that can reduce friction, improve clarity, and protect performance.
That is why video is such a strong value-add. It can help speed recruitment by making studies easier to understand. It can strengthen consent by improving participant comprehension and satisfaction. It can standardize site training and reduce execution drift. And it can support patients between visits, improving confidence and consistency. Each of those benefits maps directly to sponsor priorities: faster enrollment, fewer deviations, better retention, stronger data quality, and a better participant experience. (PubMed)
Final Thought
Clinical trials are too complex and too expensive to leave critical communication to chance.
For CROs, video offers an opportunity to deliver greater value to sponsors at every stage of the trial lifecycle. It turns complexity into clarity. It helps sites execute more consistently. It helps participants feel more informed and supported. And when communication improves, trial performance often improves with it. (JMIR)
For CROs, video creates an opportunity to deliver greater value to sponsors at every stage of the trial lifecycle. It can help accelerate recruitment, improve informed consent, standardize site training, support patient adherence, and create a more consistent experience across sites, stakeholders, and study participants.
When communication improves, trial performance improves with it.
Ready to put video to work across your clinical trial lifecycle? Partner with a team that understands how to create effective, compliant video content for CROs, sponsors, and IRB-sensitive environments, that’s ready for a global audience. Get started with SpotOn Productions.